We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

On Monday, Moderna Inc (MRNA) stock saw a decline, ending the day at $53.8 which represents a decrease of $-0.30 or -0.55% from the prior close of $54.1. The stock opened at $53.82 and touched a low ...

The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...